-
Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data
Wednesday, December 7, 2016 - 12:43pm | 332Read More...The market's bullish response to Neovasc Inc (US) (NASDAQ: NVCN)'s announcement that Boston Scientific Corporation (NYSE: BSX) was set to buy a 15 percent stake in the company was bolstered by a positive data release on Neovasc's Tiara mitral valve. Shares gained 70 percent over the trading day...


